Serologic allogeneic chimerism

Transplantation

Volumn 64, Issue 6, 1997, Pages 865-871

  McDonald, John C ^a,b   Adamashvili, Irina ^a   Zibari, Gazi B ^a   Aultman, Donnie F ^a   Mancini, Mary C ^a   McMillan, Robert W ^a   Gelder, Frank B ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHIMERA; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HEART GRAFT; HLA SYSTEM; HUMAN; HUMAN TISSUE; HYPOTHESIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-A2 ANTIGEN; HLA-A3 ANTIGEN; HUMANS; IMMUNOGLOBULIN ALLOTYPES; ISOANTIGENS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030766603     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709270-00013     Document Type: Article

References (38)

1. Hisanaga M, Hundrieser J, Boker K, et al. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation 1996; 61(1): 40.
2. Caillat-Zucman S, Legendre C, Suberbielle C, et al. Microchimerism frequency two to thirty years after cadaveric kidney transplantation. Hum Immunol 1994; 41(1): 91.
3. Goto S, Kamada N, Lord R, Kobayashi E, Enosawa S, Kim YL. Induction of natural chimerism after retransplantation of the liver in rats. Transplantation 1994; 58(11): 1230.
4. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339(8809): 1579.
5. Starzl TE, Demetris AJ, Trucco M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340(8824): 876.
6. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance [see comments]. Hepatology 1993; 17(6): 1127.
7. Adamashvili IM, McDonald JC, Fraser PA, Milford EL, Pressly TA, Gelder FB. Soluble class I HLA antigens in patients with rheumatoid arthritis and their families. J Rheumatol 1995; 22(6): 1025.
8. McMillan RM, Gelder FB, Zibari GB, Aultman DF, Adamashvili I, McDonald JC. Soluble HLA class I in the serum of liver transplant recipients. Clin Transpl 1997; 11: 98.
9. Adamashvili IM, Fraser PM, McDonald JC. Association of serum concentrations of soluble class I HLA with HLA allotypes. Transplantation 1996; 61(6): 984.
10. Gelder FB, McDonald JC, Landreneau MD, McMillan RM, Aultman DF. Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients. Ann Surg 1991; 213(6): 591.
11. McDonald JC, Gelder FB, Aultman DF, et al. HLA in human serum: quantitation of class I by enzyme immunoassay. Transplantation 1992; 53(2): 445.
12. McDonald JC, Adamashvili I, Hayes JM, Aultman DF, Rhynes VK, Gelder FB. Soluble HLA class II concentrations in normal individuals and transplant recipients: comparison with soluble HLA class I concentrations. Transplantation 1994; 58(11): 1268.
13. Pollard SG, Davies HF, Calne RY. Peroperative appearance of serum class I antigen during liver transplantation. Transplantation 1990; 49(3): 659.
14. Davies HS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47(3): 524.
15. Zavazava N, Kraatz E, Gassel AM, Muller-Ruchholtz W. Plasma MHC class I expression in cardiac graft patients: donor-specific soluble antigen in a presensitised graft patient. Transplant Proc 1991; 23(4): 2258.
16. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 1994; 40(3): 191.
17. Brodsky B, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979; 47: 3.
18. Berger B, Davis JE, Cresswell P. Monoclonal antibody to HLA-A3. Hybridoma 1982; 1(2): 87.
19. Nakane PK, Kawavi A. Peroxidase labeled antibody: a new method of conjugation. J Histochem Cytochem 1974; 22: 1084.
20. Rhynes VK, McDonald JC, Gelder FB, et al. Soluble HLA class I in the serum of transplant recipients. Ann Surg 1993; 217(5): 485.
21. Zavazava N, Leimenstoll G, Muller-Ruchholtz W. Measurement of soluble MHC class I molecules in renal graft patients: a noninvasive allograft monitor. J Clin Lab Anal 1990; 4(6): 426.
22. Zavazava N, Bottcher H, Ruchholtz WM. Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 1993; 42(1): 20.
23. Puppo F, Pellicci R, Brenci S, et al. HLA class-I-soluble antigen serum levels in liver transplantation: a predictor marker of acute rejection. Hum Immunol 1994; 40(3): 166.
24. Renna Molajoni E, Puppo F, Brenci S, et al. Serum HLA class I soluble antigens: a marker of acute rejection following liver transplantation. Transplant Proc 1995; 27(1): 1155.
25. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223(205): 472.
26. Van Rood JJ, van Leeuwan A, van Santen MCT. Anti HLA-A2 inhibitor in normal human sera. Nature 1970; 226: 366.
27. Burlingham WJ, Fechner JH, DeVito LD, Sollinger HW, Knechtle SJ, Grailer AP. Human interleukin-2 and lymphoproliferative (T-helper cell) responses to soluble HLA class I antigens in vitro: I. Specificity for polymorphic domains. Tissue Antigens 1993; 42(1): 35.
28. Claus R, Werner H, Schulze HA, Walzel H, Friemel H. Are soluble monocyte-derived HLA class II molecules candidates for immunosuppressive activity? Immunol Lett 1990; 26(3): 203.
29. Claus R, Hausmann S, Zavazava N, et al. In vitro effects of solubilized HLA-DR-role in immunoregulation? Cell Immunol 1994; 155(2): 476.
30. Jendro M, Goronzy JJ, Weyand CM. Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity 1991; 8(4): 289.
31. King DW, Reed E, Suciu-Foca N. Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance. Immunol Res 1989; 8(4): 249.
32. Krensky AM. T cells in autoimmunity and allograft rejection. Kidney Int Suppl 1994; 44: S50.
33. Nicolle MW, Nag B, Sharma SD, et al. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest 1994; 93(4): 1361.
34. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 1993; 56(2): 461.
35. Ludwig J, Hashimoto E, Porayko MK, Therneau TM. Failed allografts and causes of death after orthotopic liver transplantation from 1985 to 1995; decreasing prevalence of irreversible hepatic allograft rejection. Liver Transplant Surg 1996: 2(3): 185.
36. Suciu-Foca N, Reed E, D'Agati VD, et al. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 1991; 51(3): 593.
37. Mathew JM, Shenoy S, Phelan D, Lowell J, Howard T, Mohanakumar T. Biochemical and immunological evaluation of donor-specific soluble HLA in the circulation of liver transplant recipients. Transplantation 1996; 62(2): 217.
38. Krangel MS. Unusual RNA splicing generates a secreted form of HLA-A2 in a mutagenized B lymphoblastoid cell line. EMBO J 1985; 4(5): 1205.